1-4 of 4
Jing Bao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Orelabrutinib plus bendamustine-rituximab (OBR) Versus Bendamustine-rituximab (BR) in transplant-ineligible, intermediate- to high-risk Mantle Cell Lymphoma (MCL)

Free
Li Wang, Jianzhen Shen, Yaohui Huang, Jing Bao, Lin Shen, Pengpeng Xu, Shu Cheng, Hongming Zhu, Weili Zhao
Journal: Blood
Blood (2025) 146 (Supplement 1): 3599.
https://doi.org/10.1182/blood-2025-3599
Published: 2025
Journal Articles

Orelabrutinib in Patients with Indolent Non-Hodgkin Lymphoma (iNHL) Who Are Intolerant to Prior Bruton Tyrosine Kinase Inhibitors (BTKi): Updated Results from a Phase 2 Study

Free
Lin Shen, Jing Bao, Lihong Shou, Ying Lu, Qi Zhu, Li Wang, Weili Zhao
Journal: Blood
Blood (2024) 144 (Supplement 1): 4399.
https://doi.org/10.1182/blood-2024-204547
Published: 2024
Journal Articles

Relative Efficacy of Steroid Therapy in Ameliorating Autoimmune Thrombocytopenia Mediated by Anti-Platelet GPIIbIIIa Versus GPIbα Antibodies.

Free
Lili Tao, MD, Jing Bao, MD, Lingyan Zhu, MD, Huawei Miao, MD, Mingzhen Yang, MD, Lingjie Zhang, PhD, Ruixiang Xia, MD, Qingshu Zeng, MD, Heyu Ni, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1323.
https://doi.org/10.1182/blood.V114.22.1323.1323
Published: 2009
Journal Articles

Impact of the Inhibitory KIR-HLA Receptor-Ligand Model on Unrelated Hematopoietic Stem Cell Transplantation in Patients with Leukemia.

Free
Jun He, Zi-xing Chen, Xiao-jing Bao, De-pei Wu, Xiao-ni Yuan, Ai-ning Sun, Li Yao, Jian-nong Cen, Qiao-cheng Qiu
Journal: Blood
Blood (2007) 110 (11): 5063.
https://doi.org/10.1182/blood.V110.11.5063.5063
Published: 2007